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HistologyAbstract Zinc(II) complex with 20-[1-(2-hydroxyphenyl) ethylidene] benzenesulfanohydrazide, was
synthesized, and structurally characterized by elemental analysis CHN, TGA, UV, FT-IR, 1H
NMR and 13C NMR spectroscopy. Its preventive effect on ulcer activity induced by absolute eth-
anol in Sprague–Dawley rats was studied in vivo. Gastric ulcers were induced in rats by administrat-
ing absolute ethanol. Twenty four Spragu–Dawley rats (12 males and 12 females) were assigned
equally into the following 4 groups (n= 6): negative control; positive control; low dose, which
received low oral doses of the compound; and high dose, which received high oral doses of the com-
pounds . These animals were subjected to overnight fasting (food but not water) prior to dosing.
Gastric wall mucus, ulcer areas and histology of gastric walls were assessed in addition gastric
homogenate was determined for superoxide dismutase (SOD), glutathione (GSH) and malondialde-
hyde (MDA). Pre-treatment of rats with compound signiﬁcantly prevented ethanol-induced gastric
wall depletion and restored non-sulfhydryl (NP-SH) content in glandular stomachs. The Zinc(II)
complex also exhibits high levels of SOD, and GSH enzymes as well as a reduced amount of lipid
peroxidation enzyme, malondialdehyde. This study describes a model to produce extensive gastric
necrosis in rats by induction with absolute ethanol. The administration of zinc(II) complex with
S1198 N.S. Gwaram et al.benzensulfanohydrazone at 30 min before induction with absolute ethanol reduced or totally
eliminated lesions.
ª 2012 Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an open access
article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).Figure 1 Molecular structure of Zn (BzSO–HAP)-complex.1. Introduction
ASchiff base of benzenesulfanohydrazones thatwas synthesized
from a zinc(II) acetate metal ion and benzenesulfanohydrazide
with hydroxyacetophenone was found to possess a signiﬁcant
preventive effect on ulcer activity induced by absolute ethanol
in Sprague–Dawley rats. After the synthesis and chemical study
of this compound to conﬁrm the structure, a biological study
was run. Oral administration of benzenesulfanohydrazone
(low dose 50 mg/kg and high dose 100 mg/kg) before absolute
ethanol administration inhibited gastric lesions formation (93–
100% reduction) without increasing the mucus weight com-
pared to the control group. Based on its structure and potentials
to generate hydroxyl radicals, the compound can be described as
an oxidant and appears to increase the load of free radicals. The
carbonyl group in the compound appears to achieve the antiox-
idant balance and to protect the gastric mucosa from injurious
agents. Therefore, this group can play a role as an electrophilic
acceptor in the structure. The mechanism of cytoprotective
activity has been suggested tobemediated througha reactionbe-
tween the electrophilic acceptor and the sulfhydryl-containing
groups of the mucosa. Hydroxyl group-containing compounds
can form hydroxyl radicals, which are known to play a major
role in the pathogenesis of gastric mucosal injury. These results
suggested that benzenesulfanohydrazones prevented ethanol in-
duced gastric mucosal lesions by reducing the damaging effects
of free radicals. There are literature reports on the antimicrobial
activities for benzenesulfanohydrazones and their complexes
(Tawﬁk et al., 1989).
Previous work on the synthesis and characterization of
Schiff base ligands has revealed that these compounds display
antibacterial (Ali et al., 2006), antiproliferative and antiviral
activities (Paola et al., 2003), as well as more potent antioxida-
tive activities than vitamin E (Ali et al., 2006). The present
study extends these previous works by using different com-
pounds with varying biological activities. Very few studies
have been reported on Schiff bases of benzosulfanohydrazones
and their biological activity especially as anti-ulcerogenic
agents. An ulcer is an open sore, or lesion, usually found on
the skin or mucous membrane areas of the body. A peptic
ulcer is a lesion occurring at the lining of the stomach or duo-
denum, where hydrochloric acid and pepsin are present. In the
past, it was believed that lifestyle factors, such as stress and
diet, could cause ulcers. Later, researchers determined that
stomach acids such as hydrochloric acid and pepsin contribute
to ulcer infection. Today, research indicates that the most
ulcers (80% of gastric ulcers and 90% of duodenal ulcers) de-
velop as a result of infection with a bacterium calledHelicobac-
ter pylori (H. pylori). Although all 3 factors – lifestyle,
stomach acid, and H. pylori – play a role in ulcer development,
H. pylori is thought to be the primary cause.
Many of the past successes in medicinal chemistry have
involved the fortuitous discovery of useful pharmaceuticalagents from natural sources, such as plants or microorganisms.
Analogues of these structures were then made in an effort to
improve activity and/or to reduce side-effects, but often these
variations were identiﬁed on a trial-and-error basis. While this
approach yielded a large range of medicinal compounds, it was
wasteful with respect to the time and effort involved. In the last
20–30 years, greater emphasis has been placed on rational drug
design whereby drugs are designed to interact with a known
biological system. An early example of this rational approach
to drug design was the development of the anti-ulcer drug
cimetidine by scientists at Smith, Kline, & French (SK&F)
(Patrick, 2001). As part of an ongoing study of Schiff base
complexes, we aimed to synthesis and study the bioactivity
of 20-[1-(2-hydroxyphenyl)ethylidene]benzenesulfanohydrazide
complex with Zn(II) ion. UV–Vis, IR, 1H NMR, 13C NMR
and thermo gravimetric analyses (TGA) spectroscopy were
used to examine the coordination site of the ligand and geom-
etry of the complex (Fig. 1).
2. Experimental
2.1. Materials and measurements
All chemicals used in this study were obtained from Fluka and
Aldrich. They were used as received without further puriﬁca-
tion. UV spectra were obtained with a Shimadzu UV-1650
pc UV–Vis spectrophotometer. Infrared spectra were obtained
by using KBr discs (400–4000 cm1) on a Perkin–Elmer FT–
IR spectrometer. 1H and 13C NMR spectra were recorded on
a Jeol JNM-LA400 FT–NMR system. Tetramethylsilane
(TMS) was used as internal standard, and deuterated DMSO
was used as a solvent. Elemental analysis (C, H, N) were per-
formed on a Flash EA 1112 Series elemental analyzer at the
University of Technology Malaysia. Thermal gravimetric anal-
ysis was recorded with a Perkin Elmer TGA 4000 Thermo-
gravimetric Analyzer.
2.2. Synthesis of Zn(BzSO–HAP)-complex
A solution of zinc(II) acetate (0.15 g, 0.0006 mole) in basiﬁed
ethanol (50 ml) was mixed with a (50 ml) ethanolic solution
Synthesis, spectral characterization and biological activity of Zn(II) S1199of 20-[1-(2-hydroxyphenyl) ethylidene] benzenesulfanohydraz-
ide (0.35 g, 0.0012 mol) at a 1:2 M ratio. The mixture was stir-
red and reﬂuxed for 5 h. Dark brown solid was formed.
Yield = 65%, m.p. = 160 C. Anal. Calcd. (found)% for
C28H26N4S2O6: C, 52.77 (51.36); H, 4.08 (5.07); N, 8.79
(7.25). UV spectra (DMSO): 270, 280 nm (pﬁp*), 320 nm
(nﬁp*). IR spectra (KBr): 3172 cm1 m(N–H), 1600 cm1
m(C‚N), 1353 cm1 m(S‚O), 1164 cm1 m(S‚O), 1087 cm1
m(CO), 1035 cm1 m(N–N), 441 cm1 m(M–N), 503 cm1
m(M–O), 1H NMR (DMSO): 12.93 ppm [d (N–H)], 6.70–
7.74 ppm [d(aromatic), m], 2.16 ppm [d(–CH3), 3H, s] and
13C NMR (DMSO): 157.76 ppm d(C‚N), 116.33–
131.35 ppm d(aromatic), 13.13 ppm d(–CH3).
2.3. Biological experiments
2.3.1. Ethics statement
Animal experiments were performed in accordance with the
guidelines for animal experimentation issued by the Animal
Care and Use Committee at the University of Malaya (Ethics
Number: PM/27/07/2010/MAA (R)).
2.3.2. Chemical derivatives
Tween 20 was manufactured by Merck Schuchardt OHG.
85662 Hohen brunn, Germany and Cimetidine was the refer-
ence antiulcer drug, which was obtained from the University
Malaya Medical Centre. Each tablet contained 200 mg of
Cimetidine; the tablets were ground to powder and suspended
in the vehicle (tween 20, 10%v/v) and administered to the rats
in a concentration of 50 mg/kg orally as described by (Tan
et al., 2000).
2.3.3. Experimental animals
Sprague–Dawley healthy adult male rats were obtained
from the Experimental Animal House, Faculty of Medicine,
University of Malaya. The rats were divided randomly into 6
groups of 6 rats each. Each rat 200–225 g was placed
individually in a separate cage (1 rat per cage) with wide-mesh
wire bottoms to prevent coprophagia during the experiment.
The animals were maintained on standard pellet diet and tap
water.
2.3.4. Acute toxicity studies
An acute toxicity study was used to determine a safe dose for
Zn(BzSO–HAP). Forty eight healthy Sprague–Dawley rats (24
males and 24 females) were obtained from the Experimental
Animal House, Faculty of Medicine, University of Malaya.
The rats were assigned equally to 4 groups, which were labeled
as vehicle (gum acacia in normal saline), 1 g/kg, 2 g/kg, or 5 g/
kg of Zn(BzSO–HAP) in vehicle. The animals were fasted
overnight (food but not water) prior to dosing. Food was
withheld for a further 3–4 h after dosing. The animals were ob-
served for 30 min and at 2, 4, 24 and 48 h after administration
for the onset of clinical or toxicological symptoms. Mortality,
if any was observed over a period of 2 weeks. The animals were
sacriﬁced on day 15. Hematological, serum biochemical and
histological (liver and kidney) parameters were determined
with standard methods (Bergmeyer, 1980; Tietz et al., 1983).
Throughout the experiments, all animals received humane care
according to the criteria outlined in the ‘‘Guide for the Care
and Use of Laboratory Animals’’ prepared by the National
Academy of Sciences and published by the National Institute
of Health.2.3.5. Gastric ulcer-induction by ethanol
Gastric ulcers were induced in rats by administrating absolute
ethanol according to the recommendation of (Mahmood
et al., 2010). The experimental animals were divided into 4
groups (n= 6) and the negative control animals received
5 ml kg1 of 10% Tween 20 orally by metal or gastric intuba-
tions (per os); positive control animals received oral doses of
50 mg kg1 cimetidine in (5 ml kg1) suspended in 10% Tween
20; high dose animals received oral doses of 100 mg kg1 of the
compound (5 ml kg1) suspended in 10% Tween 20; and low
dose animals received oral doses of 50 mg kg1 of the com-
pound (5 ml kg1) suspended in 10% Tween 20. After 30 min
of the pre-treatment, 5 ml kg1 of absolute ethanol was admin-
istered orally to the animals. The animals were killed 30 min la-
ter by overdoses of xylazin and ketamine anesthesia (Mahmood
et al., 2010) and their stomachs were excised. Each stomach was
opened along the greater curvature, washed with distilled water
and ﬁxed in 10% buffered formalin (Morimoto et al., 1991).
2.3.6. Preparation of homogenate
Gastric tissue was washed thoroughly with ice cold saline. 10%
(w/v) homogenate was prepared tephlon homogenizer (Poly-
tron, Heidolph RZR 1, Germany) in ice-cold 50 mM phos-
phate buffer pH 7.4 containing mammalian protease
inhibitor cocktail. The homogenate was centrifuged at
10,000g for 30 min at 4 C. The supernatant was used for the
assay of antioxidant activities/levels and lipid peroxidation.
2.3.7. Measurement superoxide dismutase (SOD) activity
SOD activity was measured according to Sun et al. (1988). The
activity of the enzyme was evaluated by measuring its capacity
to inhibit the photochemical reduction of nitro-blue tetrazo-
lium (NBT). In this assay, the photochemical reduction of
riboﬂavin generates O2 that reduces the NBT to produce for-
mazan salt, which absorbs at a wavelength of 560 nm. In the
presence of SOD, the reduction of the NBT is inhibited be-
cause the enzyme converts the superoxide radical to peroxide.
The results are expressed as the quantity of SOD necessary to
inhibit the rate of reduction of the NBT by 50% in units of the
enzyme per gram of protein. Homogenates (10% of tissue in
buffer phosphate) were centrifuged (10 min, 3600 rpm, 4 C),
and the supernatant was removed and centrifuged a second
time (20 min, 12,000 rpm, 4 C). The resulting supernatant
was assayed. In a dark chamber, 1 mL of the reactant
(50 mM phosphate buffer, 100 nM EDTA and 13 mM L-
methionine, pH 7.8) was mixed with 30 lL of the sample,
150 lL of 75 lM NBT and 300 lL of 2 lM riboﬂavin. The
tubes containing the resulting solution were exposed to ﬂuores-
cent light bulbs (15 W) for 15 min and then read using a spec-
trophotometer at 560 nm.
2.3.8. Measurement of the amount of reduced glutathione
To assess the changes in the gastric mucosal amount of GSH (a
non-protein sulfhydryl compound), its content was measured
according to the method described by Sedlak and Lindsay
(1968). The glandular segment from each stomach was homog-
enized in ice-cold 0.02 M EDTA solution (at 10%). Aliquots
(400 lL) of tissue homogenate were mixed with 320 lL of dis-
tilled water and 80 lL of 50% (w/v) trichloroacetic acid in
glass tubes and centrifuged at 3000 rpm for 15 min. Subse-
quently, supernatants (400 lL) were mixed with 800 lL Tris
buffer (0.4 M, pH 8.9) and 5,5-dithio-bis(2-nitrobenzoic acid)
S1200 N.S. Gwaram et al.(DTNB; 0.01 M) was added. After shaking the reaction mix-
ture for 3 min, its absorbance was measured at 412 nm within
5 min of the addition of DTNB against a blank with no
homogenate. The absorbance values were extrapolated from
a glutathione standard curve and the GSH content was ex-
pressed in microgram GSH/g of protein. The concentration
of proteins was measured using the method described by Brad-
ford (1976).
2.3.9. Measurement of the membrane lipids peroxidation
The rate of lipoperoxidation in the gastric mucous membrane
was estimated by determination of malondialdehyd (MDA)
using the Thiobarbituric Acid Reactive Substances (TBARS)
test. The stomachs were washed with saline to minimize the
interference of hemoglobin with free radicals and to remove
blood adhered to the mucous membrane. The stomachs were
homogenized to 10% of tissue with potassium phosphate buf-
fer. Then, 250 lL was removed and stored at 37 C for 1 h,
after which 400 lL of 35% perchloric acid was added, and
the mixture was centrifuged at 14,000 rpm for 20 min at
4 C. The supernatant was removed, mixed with 400 lL of
0.6% thiobarbituric acid and incubated at 95–100 C for 1 h.
After cooling, the absorbance at 532 nm was measured. A
standard curve was generated using 1,1,3,3-tetrametoxypro-
pane. The results were expressed as nmol of MDA/mg of pro-
tein. The concentration of proteins was measured using the
method described by Bradford (1976). The method is based
on the interaction of the Coomassie Blue G250 dye with pro-
teins. At the pH of the reaction, the interaction between pro-
teins of high molecular weight and the dye causes a shift in
the dye to the anionic form, which absorbs strongly at
595 nm. Solutions of albumin standard, distilled water, buffer
and samples were added to the wells. For sample preparation,
2 lL of sample and 38 lL of buffer were added to each well.
Then, 200 lL Bradford’s solution (diluted 5·) was added to
each well. After 5 min, a reading was taken at the wavelength
of 595 nm (Bradford, 1976).
2.3.10. Biochemical assays of SOD, GSH and MDA in gastric
tissue homogenate
In gastric tissue, both SOD and GSH activities in ulcer control
group were signiﬁcantly lower compared with normal group
(Table 5). Administration of cimetidine or compounds before
absolute alcohol signiﬁcantly rose the SOD and GSH com-
pared with ulcer control group (Table 5). Administration of
absolute alcohol signiﬁcantly increased the MDA level of gas-
tric homogenate compared with normal control. Administra-
tion of cimetidine or compound decreased the MDA level in
gastric tissue compared with ulcer control group (Table 5).
The results indicated that GSH levels in tissue homogenate
in animals-treated with cimetidine or compound increased if
compared to the ulcer control group, demonstrating a possible
antioxidant capacity of compound (Table 5).2.3.11. Macroscopic examination
The abdomens of the rats were opened and the pylorus of each
was ligated. The stomachs were removed and the gastric juice
was obtained from each stomach. The surface area (mm2) cov-
ered by each lesion was measured (Mahmood et al., 2010) and
the sum of the erosion areas per rat stomach was calculated by
using a dissecting microscope at a magniﬁcation of ·1.8. Thepercentage of ulcerated surfaces (US), was calculated as fol-
lows: US (mm2) = (total area covered by ulcers/total corpus
mucosal surface) · 100. The ulcer index (UI) for each animal
was calculated as the mean ulcer score. Percentage inhibition
(%I) was determined as follows: [(UI in controlUI in test
group)/UI in control group] · 100 (Mahmood et al., 2010).
The stomach contents were collected and centrifuged. The gas-
tric juice was separated from the mucus. The mucus content
was weighed and expressed in terms of grams (Varley et al.,
1980).
2.3.12. Microscopic examination (histology examination)
The stomach was cut into small pieces of tissues and was ﬁxed
in 10% buffered formalin overnight. The tissues were pro-
cessed in an automated tissue processor through dehydration,
cleaning and impregnation steps. Next, the tissues were embed-
ded in parafﬁn wax and sectioned into 5 lm thick section by
votary microtome. The sections were stained with hematoxylin
and eosin. Each specimen was analyzed under a light micro-
scope at ·10, ·40 and ·100 magniﬁcation to observe changes
in the tissues structures compared to the control group (Mah-
mood et al., 2010; Holander et al., 1984).
2.3.13. Statistical analysis
The results are expressed as the standard error of the mean
(S.E.M.). The statistical differences of each group of rats were
calculated by using Student’s t-test with SPSS for Windows
Evaluation Version 14. Statistically signiﬁcant differences were
accepted at P< 0.05 level.
3. Results
3.1. Thermal studies
The thermal decomposition of the Zn(II) complex was investi-
gated by (TGA). The results showed good agreement with the
formula suggested from the analytical data. A general decom-
position pattern was obtained, in which the complex decom-
posed in 4 steps as shown in (Spectrum 1). The ﬁrst and
second stages involved the loss of water molecules at 45.27–
98.50 C and 98.50–180.63 C respectively. The third and
fourth stages involved the loss of part of the organic ligand.
Moreover, the Zn(II) complex decomposed and produced
ZnO2 as a residue (Gouda et al., 2009; Chen et al., 2010; Elbeh-
ery and El-Twigry, 2007). The experimental determination of
the complex by TGA is presented in Table 1.
3.1.1. 1H and 13C NMR spectroscopy
1H and 13C NMR spectra Zn(BzSO–HAP)-complex is re-
corded in d6-dimethylsulfoxide (DMSO) solution with chemi-
cal shifts expressed in ppm using tetramethylsilane (TMS) as
internal standard. The important data are given in the experi-
mental part.
1H NMR spectra displayed singlet signals in the 12.93 ppm
which assigned to N–H group. The other singlet signals ap-
peared in the region of 2.16 ppm which is assigned to protons
of methyl group for acetophenone. The aromatic ring protons
of Zn(BzSO–HAP) are observed as multiplets in the region of
0.70–7.74 ppm.
The 13C NMR spectra of the compound conﬁrm the 1H
spectral results. The azomethine group C‚N was observed
downﬁeld in the 157.76 ppm chemical shift, while the aromatic
Spectrum 1 TGA spectrum of Zn(BzSO–HAP)-complex.
Table 1 TGA data of the Zn(BzSO–HAP)-complex.
Complex Step Temp. (oC) Weight loss (%) found
(calculated)
Assignment Residue (%) found
(calculated)
Zn(II) 1 45.27–98.50 1.49(2.61) H2O ZnO 16.03(14.12)
2 98.50–180.63 2.25(2.61) H2O
3 182.15–315.98 71.49(72.38) (Ph–SO2–NH–N‚C–CH3)2ÆPh–CH3ÆCH3
4 315.98–618.64 10.21(10.87) Ph–
Synthesis, spectral characterization and biological activity of Zn(II) S1201ring signals were observed in the region of 116.33–131.35 ppm.
The peak up ﬁeld in the region of 13.13 ppm is assigned to
methyl group, CH3 of the zinc complex.
3.1.2. FT-IR spectroscopy
The IR spectra shifts of Zn(BzSO–HAP)-complex is summa-
rized in the experimental part. The major functional groups fo-
cused on the vibration of m(NH), m(C‚N), m(C–O), mas(SO2),
and m s(SO2) which provide conclusive structural evidence for
the coordination of the ligand to the central metal atoms.
The complex displays the m(C‚N) band at 1600 cm1 at a
lower wave number indicating a decrease in the bond order
due to the coordination of the metal atom to the azomethine
nitrogen lone pair. The higher wave number of m(N–N)at
1035 cm1 is an evidence of this coordination.
There are two bands at the wave number of 1353 cm1 and
1164 cm1 assigned to two (S‚O) groups. The new bands in
441 and 503 cm1 were assigned as m(M–N) and m(M–O)
bonds, respectively.
3.1.3. UV–Visible spectroscopy
The electronic absorption data of the compound are given in
the experimental part. In the spectrum the shoulder band in
the 320 nm was assigned to the nﬁp* transition of the azome-
thine group. The intense bands in the 270, 280 nm are attrib-
uted to the pﬁp* transition of the azomethine group and
benzene ring, the high energy transition observed is suggestingthat the nitrogen atom of the azomethine group is coordinated
to the metal ion.
3.2. Biological activity
3.2.1. Acute toxicity study
Animals treated with Zn(BzSO–HAP) at a dose of 2 g/kg or
5 g/kg were kept under observation for 14 days. All of the ani-
mals remained alive and no animal manifested any signiﬁcant
sign of toxicity at these doses. There were no abnormal signs,
behavioral changes, body weight changes, or macroscopic ﬁnd-
ing at any time of observation. There was no mortality in the
above-mentioned doses at the end of 14 days of observation.
Histological examination of the liver and kidney, hematology,
and serum biochemistry revealed no signiﬁcant differences
between the different groups as shown in Fig. 2. All of the data
of the acute toxicity tests are listed in Tables 2 and 3.
3.2.2. Cytoprotective activity
The metal compound in Table 4 showed an important cytopro-
tective activity against ulcers induced by absolute ethanol. The
values of ulcer area, percentage of ulcer inhibition and pH
compared with those of the cimetidine group showed that
the compound is bioactive.
The ulcer areas in the benzenesulfanohydrazone treated
groups were signiﬁcantly smaller than the control group. As
can be observed in Table 4 the oral administration of the metal
Table 2 Acute toxicity test.
Animals group Renal function test
Sodium
(mmol/L)
Pottasium
(mmol/L)
Chloride
(mmol/L)
CO2
(mmol/L)
Anion gap
(mmol/L)
Urea
(mmol/L)
Creatinine
(lmol/L)
Control grp 138.17 ± 2.64 5.12 ± 0.09 103.33 ± 1.91 23.13 ± 0.88 18.17 ± 0.60 5.73 ± 0.37 50.83 ± 1.79
L. D. (2 g/kg) 137.67 ± 1.65 5.30 ± 0.05 102.67 ± 1.60 20.42 ± 0.61 19.17 ± 0.40 4.85 ± 0.08 47.67 ± 1.22
H. D. (5 g/kg) 138.50 ± 1.59 4.63 ± 0.04 102.83 ± 1.69 22.9 ± 0.36 17.33 ± 0.42 5.98 ± 0.21 48.00 ± 1.16
All values expressed as mean and standards error mean. There is no signiﬁcant difference between groups.
Figure 2 Histological sections of acute toxicity test. a, b and c (20·) liver section in rats treated with 5 g/kg vehicle, LD and HD
compound, respectively. (d, e (20·) and f (10·)) Kidney section in rats treated with 5 ml/kg vehicle. There is no signiﬁcant differences in
structures of liver and kidney between treated (LD, HD) and control groups.
S1202 N.S. Gwaram et al.complex (50 and 100 mg/kg) at 30 min before ethanol admin-
istration markedly reduced the mucosal damage by up to
100% in animals treated with a high dose of the compound.
At the same time the compound did not induce any signiﬁcant
changes in the normal gastric mucosa of the rats of any tested
group. The results of the present study conﬁrm the known
ulcerogenic effects of ethanol. The chemical structure (Fig. 1)
shows that the benzenesulfanohydrazones complexes have hy-
droxyl coordinated groups. Based on its structure and poten-
tials to generate hydroxyl radicals, benzenesulfanohydrazone
complexes can be described as oxidants and appear to increase
the load of free radicals. The carbonyl group in the compounds
appears to achieve the antioxidant balance and to protect the
gastric mucosa from injurious agents. Therefore, this group
may play a role as an electrophilic acceptor in the structure.
The mechanism of cytoprotective activity has been suggested
to be mediated through a reaction between the electrophilic
acceptor and the sulfhydryl-containing groups of the mucosa.
Also, compounds with the hydroxyl group can form hydroxyl
radicals, which are known to mediate in the pathogenesis of
gastric mucosal injury. This result has been reported in a study
(Al-shabanah et al, 2000) about the effect of ninhydrin on thebiochemical and histopathological changes in the gastric mu-
cosa of rats. Further studies are warranted to identify the de-
tailed mechanism of action of these bioactive compounds.
The administration of ethanol to rats produces gastric
mucosal lesions and erosions similar to those occurring in gas-
tric ulcer. These lesions are produced because ethanol can af-
fect the protective defense mechanisms at the mucosal layer
(Repetto and Liesuy, 2002). This study describes a model to
produce extensive gastric necrosis in rats after induction with
absolute ethanol. Once administered to rats, the ethanol rap-
idly penetrates the mucosa layer and causes extensive damage
(Rajeshkumar et al., 2001; Abdulla et al., 2010). This process
supports the ﬁnding that only 30 min was needed to produce
acute gastric ulceration in rats. Administration of absolute eth-
anol to fasted rats caused severe gastric damage, which was
visible from the outside of the stomach as thick reddish-black
lines in the ulcerated control group (Fig. 3). Administration of
the zinc(II) metal complex of benzenesulfanohydrazones at
30 min before the administration of absolute ethanol lead to
good prevention with reduction or absence of the lesions. This
result shown in Fig. 3 is the view of the outside of the stomach
and (Fig. 4) is the view of the opened stomach.
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The histological analysis of ethanol treated and control rat
stomachs revealed the presence of necrotic debris in the lamina
propria of the mucosa. The lesions extended down the mucosal
layer involving the surface epithelium (Fig. 5). The treated
groups had less damage along the surface of the epithelium.
Mucosal blood ﬂow has been observed to be an important fac-
tor in the damage caused by alcohol and is modulated by pros-
taglandin (Holander et al., 1984). The effectiveness of
benzenesulfanohydrazones complex in prevention against
mucosal damage caused by ethanol may be an indication of
its effect on prostaglandin as shown in Fig. 6.4. Discussion
4.1. Chemistry
To determine the safety of drugs and products for human use,
toxicological evaluations are carried out in various experimen-
tal animals to predict toxicity and to provide guidelines for
selecting a safe dose in humans. The Hematological, gastroin-
testinal and cardiovascular adverse effects have the highest
overall concordance between animals and humans (Olson
et al., 2000). The liver and kidney of the treated rats showed
no signiﬁcant change compared to the control group. Hema-
tology and clinical biochemistry values were within the range
of the control animals tested and were similar to some of the
control reference values published by other researchers (Rin-
gler and Dabich, 1979; Witthawaskul et al., 2003). In acute
toxicity studies, a product is considered nontoxic if no deaths
are registered after 14 days of observation and no clinical signs
of toxicity are observed at doses 65 g/kg. Because the highest
dose of zinc(II) complex that did not cause any toxicity was
5 g/kg body weight, this ﬁnding suggests that the compound
is relatively nontoxic (Brock et al., 1995).
The effectiveness of the zinc(II) metal complex with 20-[1-(2-
hydroxyphenyl) ethylidene] benzenesulfanohydrazide in
preventing mucosal damage caused by ethanol may indicate
its effect on prostaglandin. The treatment with the benze-
nesulfanohydrazones complex reduced the volume of gastric
secretion. In the cimetidine group the gastric contents were
around (1.18 ± 0.04b) g, while those of the treated groups
were in the range of (1.33 ± 0.01c–1.40 ± 0.01d) g. This char-
acteristic indicates that the benzenesulfanohydrazones of the
zinc(II) metal complex acts similar to histamine H2 receptor
antagonists. Therefore, the cimetidine has been used as
standard antiulcer drug in the present study as it can decrease
acid output but not decrease the ulcer area. This previous
observation supports the result of the present study, in which
both doses of zinc(II) complex showed cytoprotective effects,
in terms of reducing the ulcerative area, that were similar to
the effect of cimetidine, which reduced the gastric secretion.
The inhibition activity of the zinc(II) complex with 20-[1-(2-
hydroxyphenyl) ethylidene] benzenesulfanohydrazide against
ulcer formation was excellent and was higher than that of
the cimetidine group which had a percentage of 89.83%
inhibition. As the dosage was increased further, the ulcer
inhibition increased to 100%. The reduced gastric acidity mea-
sured after pylorus ligation suggests that the cytoprotective
mechanism of action of the extract on gastric mucosa may in-
volve direct inhibition of gastric secretion. The reduction of
Figure 3 Macroscopical appearance of gastric mucosa in rats. (a) Rats pre-treated with 10% Tween 20. Severe macroscopic necrosis of
gastric mucosa. Absolute ethanol produced extensive visible hemorrhagic necrosis of gastric mucosa. (b) Rats pre-treated with cimetidine
50 mg kg1). Mild macroscopic necrosis of gastric mucosa. The drug reduces the formation of gastric lesions induced by absolute ethanol.
(c) Rats pre-treated with Zn(BzSO–HAP) (50 mg kg1). Mild macroscopic necrosis of gastric mucosa. The compound reduces the
formation of gastric lesions induced by absolute ethanol. (d) Rats pre-treated with Zn(BzSO–HAP) (100 mg kg1). The compound
prevents the formation of gastric lesions induced by absolute ethanol.
Table 4 Observed ulcer area, inhibition (percentage), pH and mucus by Zn(BzSO–HAP)2 in rats.
Animal Group Pre-treatment
(5 ml/kg dose)
Ulcer area
(mm)2 (Mean ± S.E.M)
Inhibition (%) pH of gastric
content
Mucus weight of gastric content
1 Tween 20 (ulcer control) 840.00 ± 4.60a - 3.78 + 0.154a 0.73 + 0.065a
2 Cimetidine (50 mg/kg) 145.00 ± 4.91b 82.74% 6.20 + 0.491b 1.18 + 0 .069b
3 Zn(BzSO–HAP)2 (50 mg/kg) 85.40 ± 4.43
c 89.83% 5.10 + 0.379ab 1.33 + 0.086b
4 Zn(BzSO–HAP)2 (100 mg/kg) 00.00 ± 0.00
d 100% 5.54 + 0.415b 1.40 + 0.140b
All values are expressed as mean ± standard error mean. Means with different superscripts are signiﬁcantly different. The mean difference is
signiﬁcant at the P< 0.05 level.
Table 5 Effects of Zinc(II) complex on gastric tissue homogenate enzymes (SOD, GSH) and level of MDA.
Pre-treatment SOD GSH MAD
Normal control 419.33 ± 11.44a 320.56 ± 06.85a 33.06 ± 2.02a
Ulcer control 300.22 ± 15.31b 219.75 ± 10.05b 89.61 ± 3.11b
Cimetidine 472.88 ± 17.64c 490.09 ± 11.12c 50.11 ± 1.87c
50 mg compd 488.67 ± 12.28c 435.55 ± 09.50d 41.28 ± 2.05c
100 mg compd 513.75 ± 12.98d 508.48 ± 07.66c 55.17 ± 3.82c
All values are expressed as mean ± standard error mean. Means with different superscripts are signiﬁcantly different. The mean difference is
signiﬁcant at the P< 0.05 level.
S1204 N.S. Gwaram et al.acidity observed after incubation of the gastric juice with the
extract suggests that the cytoprotective mechanism may in-
volve the simple neutralization of the acid secreted in the stom-
ach. Fig. 5b shows the effect of the benzenesulfanohydrazone
complex on the acidity of the gastric juice in pH range from
5.1 ± 0.04c to 5.54 ± 0.03d compared to the cimetidine group
(pH= 6.2 ± 0.06b). These results agree with previous studies
(Mahmood et al., 2010; Murakamu et al., 1990). In this studyzn(II) benzenesulfanohydrazone complex was found to reduce
gastric lesions induced by ethanol in vivo.
Absolute ethanol-induced gastric ulcers have been widely
used in the evaluation of gastroprotective activity (Al-Moﬂeh
et al., 2008). Ethanol is metabolized in the body and releases
superoxide anion and hydroperoxy free radicals. It has been
found that oxygen-derived free radicals are implicated in the
mechanism of acute and chronic ulceration in the stomach
Figure 5 Histological section of the absolute ethanol-induced gastric mucosal damage in rats. (5a) Rats pre-treated with 10% Tween 20
(ulcer control). Severe disruption of the surface epithelium, deep penetration of necrotic lesions into mucosa (arrow) and edema of the sub
mucosa layer (yellow arrow) with leukocyte inﬁltration of ulcerative tissues. (b) Rats pre-treated with cimetidine (50 mg/kg). Moderate
disruption of the surface epithelium and edema of the sub mucosal layer (yellow arrow) with leucocytes inﬁltration. (c) Rats pre-treated
with Zn(BzSO–HAP) (50 mg kg1). There is mild disruption of the surface epithelium. (d). Rats pre-treated with Zn(BzSO–HAP)
(100 mg kg1. No disruption to the surface epithelium (arrow) and no edema and leucocytes inﬁltration of sub mucosal layer (H&E stain,
10·).
Figure 4 Macroscopical appearance of gastric mucosa in rats in open stomach. (a) Rats pre-treated with 10% Tween 20. Severe
macroscopic necrosis of gastric mucosa. Absolute ethanol produced extensive visible hemorrhagic necrosis of gastric mucosa. (b) Rats pre-
treated with cimetidine 50 mg kg1). Mild macroscopic necrosis of gastric mucosa. The drug reduces the formation of gastric lesions
induced by absolute ethanol. (c) Rats pre-treated with Zn(BzSO–HAP) (50 mg kg1). Mild macroscopic necrosis of gastric mucosa. The
compound reduces the formation of gastric lesions induced by absolute ethanol. (d) Rats pre-treated with Zn(BzSO–HAP) (100 mg kg1).
The compound prevents the formation of gastric lesions induced by absolute ethanol.
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Figure 7 Histograms of the effects of Zinc(II) complex on gastric
tissue homogenate enzymes (SOD, GSH) and level of MDA.
Figure 6 Shows the effect of compound on ethanol induced gastric mucosal lesions in rats (a) Summarized the effect of compound on
mucosal weight. (b) Shows the effect of benzenesulfanohydrazones complex on the acidity of the gastric juice in range of
(pH = 5.1 ± 0.04c –5.54 ± 0.03d) compared to the cimetidine group (pH = 6.2 ± 0.06b). (c) Shows the inhibition of benzenesulfanohyd-
razones Zinc(II) complex 50 mg kg1 and 100 mg kg1 against the stomach ulcer induced by absolute alcohol and the results are compared
to the standard drug, cimetidine (d) this shows the Ulcer area for the compound compared with the control group and standard
cimetidine. Cimetidine has been reported to decrease acid output but did not decrease the ulcer area. This supported the present study
which both doses had indicated better cytoprotective effects in reducing ulcer area formation compared with cimetidine with less gastric
secretion.
S1206 N.S. Gwaram et al.(Umamaheswari et al., 2007). The genesis of ethanol-induced
gastric lesions is of multifactorial origin with a decrease in gas-
tric mucus and is associated with the signiﬁcant production of
free radicals leading to increased lipid peroxidation which in
turn causes damage to cells and cell membranes (Khazaei
and Salehi, 2006). Oral administration of absolute ethanol is
noxious to the stomach since it affects the gastric mucosa top-
ically by disrupting its barrier and provoking pronounced
micro vascular changes within a few minutes after its applica-
tion (Moleiro et al., 2009).
In the present study, gastric tissue homogenate (Fig. 7)
from animals pre-treated with cimetidine or compoundshowed signiﬁcant antioxidant activity by decreasing the levels
of MDA and by elevating the levels of GHS and SOD in
response to oxidative stress due to absolute ethanol (Table 5).
Lipid peroxidation is found to be an important path physio-
logical event in a variety of diseases (Ajitha and Rajnarayana,
2001). Malondialdehyde (MDA) level is a biomarker for oxi-
dative stress (Gutteridge, 1995). Apart from overproduction
of free radicals are linked to accumulation of lipid peroxida-
tion by-products (Palanduz et al., 2001). It is well known that
MDA from lipid peroxidation reacts with DNA bases and in-
duces mutagenic lesions (Benamira et al., 1995). Free radicals
and reactive oxygen species (ROS) are continuously produced
in human body. These oxygen species are the cause of cell
damage. Therefore, tissues must be protected from oxidative
injury through intracellular as well as extracellular antioxi-
dants (Halliwell and Gutteridge, 1999).
Superoxide dismutase (SOD) can catalyze the dismutation
of superoxide anions into hydrogen peroxide and dioxygen,
to keep the free radical density in the body at a normal level.
Superoxide dismutase is one of the key enzymes responsible
for radical scavenging activities. It catalyzes superoxide radi-
cals to hydrogen peroxide and oxygen. SOD converts superox-
ide to hydrogen peroxide (H2O2) which is then transformed
into water by catalase in lysosomes or by glutathione peroxi-
dase (GPx) in mitochondria (Johansen and Sagvolden, 2005).
Glutathione constitutes one of the most important protec-
tive mechanisms against lesion formation (Cnubben et al.,
2001), while SOD-mediated catalysis of superoxide radical an-
ion ðO2þÞ into less noxious hydrogen peroxide (H2O2) repre-
Synthesis, spectral characterization and biological activity of Zn(II) S1207sents the ﬁrst line of antioxidant defense. GSH is known to
protect the cellular system against the toxic effects of lipid per-
oxidation. GSH functions as direct free radical scavenger, as a
co-substrate for glutathione peroxidase (GPx) activity and as a
cofactor for many enzymes and forms conjugates in endo and
xenobiotic reactions (Gregus et al., 1996).
The antiulcer activity may be attributed to the ability of
compound to protect gastric mucus against ethanol-induced
depletion of the non-protein sulfhydryl (NP-SH) component
of the glandular mucosa. Glutathione (GSH) has been resorted
to play an important role in the process of cellular injury
(Szabo et al., 1981) have reported a prophylactic effect of glu-
tathione against various necrotizing agent. GSH exerts a piv-
otal role in maintenance of gastric integrity (Dutta et al.,
2007). Oxidative damage to the mucosal lining could be mini-
mized by superoxides scavenger like GSH.
5. Conclusion
This paper describes a model to produce extensive gastric
necrosis in rats by induction with absolute ethanol. It also de-
scribes good prevention of gastric necrosis by administration
of zinc(II) complex with benzenesulfanohydrazones 30 min be-
fore induction with absolute ethanol which reduced or elimi-
nated lesion formation. The compound was tested for acute
toxicity. Hematology and clinical biochemistry values were
within the range of the control animals tested and were similar
to some of the control reference values. The highest dose of zin-
c(II) complex that did not cause any toxicity was 5 g/kg body
weight, which indicates that the compound is relatively non-
toxic. Assays of SOD and GSH and MDA levels from gastric
tissue homogenate reveal that compound treated group signif-
icantly increases the SOD and GSH, and decreased the level of
lipid peroxidation compared with the ulcer control group.Acknowledgements
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